Shree Shivshankar Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 18-07-2024
- Paid Up Capital ₹ 1.42 M
as on 18-07-2024
- Company Age 37 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
as on 18-07-2024
- Satisfied Charges ₹ 1.34 M
as on 18-07-2024
- Revenue -70.30%
(FY 2022)
- Profit -217.90%
(FY 2022)
- Ebitda -181.60%
(FY 2022)
- Net Worth -9.21%
(FY 2022)
- Total Assets -7.64%
(FY 2022)
About Shree Shivshankar Drugs And Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.42 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹1.34 M, as per Ministry of Corporate Affairs (MCA) records.
Hanuman Banka, Rajesh Kasliwal, and Siddharth Banka serve as directors at the Company.
- CIN/LLPIN
U24200MH1987PTC044283
- Company No.
044283
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Shivshankar Drugs And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kasliwal  | Director | 10-Feb-2017 | Current |
| Hanuman Banka | Director | 10-Feb-2017 | Current |
| Siddharth Banka | Director | 10-Feb-2017 | Current |
Financial Performance of Shree Shivshankar Drugs And Pharmaceuticals.
Shree Shivshankar Drugs And Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 70.3% decrease. The company also saw a substantial fall in profitability, with a 217.9% decrease in profit. The company's net worth dipped by a decrease of 9.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Shivshankar Drugs And Pharmaceuticals?
In 2023, Shree Shivshankar Drugs And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ashish Interchem Private LimitedActive 35 years 6 months
Hanuman Banka and Siddharth Banka are mutual person
- Ashish Dye Chem And Textiles Processors Private LimitedActive 48 years 6 months
Hanuman Banka is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 29 Aug 2018 | ₹1.50 Cr | Open |
Nkgsb Co-Op. Bank Ltd. Creation Date: 06 Oct 2008 | ₹0.74 M | Satisfied |
The North Kanara G.S.B. Co-Op Rative Bank Ltd. Creation Date: 13 Feb 1991 | ₹0.60 M | Satisfied |
How Many Employees Work at Shree Shivshankar Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Shree Shivshankar Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Shivshankar Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Shivshankar Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
